Global Non-Animal Softgel Capsules Market Growth 2022-2028
As the global economy mends, the 2021 growth of Non-Animal Softgel Capsules will have significant change from previous year. According to our latest study, the global Non-Animal Softgel Capsules market size is USD million in 2022 from USD 541 million in 2021, with a change of % between 2021 and 2022. The global Non-Animal Softgel Capsules market size will reach USD 895.7 million in 2028, growing at a CAGR of 7.5% over the analysis period.
The United States Non-Animal Softgel Capsules market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Non-Animal Softgel Capsules market, reaching US$ million by the year 2028. As for the Europe Non-Animal Softgel Capsules landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Non-Animal Softgel Capsules players cover Catalent, Procaps Laboratorios, EuroCaps, and Best Formulations, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Animal Softgel Capsules market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Plant Polysaccharides Softgel Capsules
Starch Softgel Capsules
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Health Supplements
Pharmaceutical
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Catalent
Procaps Laboratorios
EuroCaps
Best Formulations
Aenova
Captek
Sirio
Bahrain Pharma
Robinson Pharma
Aland
Fuji Capsule
Sunsho Pharmaceutical
Erkang
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-Animal Softgel Capsules Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Non-Animal Softgel Capsules by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Non-Animal Softgel Capsules by Country/Region, 2017, 2022 & 2028
2.2 Non-Animal Softgel Capsules Segment by Type
2.2.1 Plant Polysaccharides Softgel Capsules
2.2.2 Starch Softgel Capsules
2.3 Non-Animal Softgel Capsules Sales by Type
2.3.1 Global Non-Animal Softgel Capsules Sales Market Share by Type (2017-2022)
2.3.2 Global Non-Animal Softgel Capsules Revenue and Market Share by Type (2017-2022)
2.3.3 Global Non-Animal Softgel Capsules Sale Price by Type (2017-2022)
2.4 Non-Animal Softgel Capsules Segment by Application
2.4.1 Health Supplements
2.4.2 Pharmaceutical
2.4.3 Others
2.5 Non-Animal Softgel Capsules Sales by Application
2.5.1 Global Non-Animal Softgel Capsules Sale Market Share by Application (2017-2022)
2.5.2 Global Non-Animal Softgel Capsules Revenue and Market Share by Application (2017-2022)
2.5.3 Global Non-Animal Softgel Capsules Sale Price by Application (2017-2022)
3 Global Non-Animal Softgel Capsules by Company
3.1 Global Non-Animal Softgel Capsules Breakdown Data by Company
3.1.1 Global Non-Animal Softgel Capsules Annual Sales by Company (2020-2022)
3.1.2 Global Non-Animal Softgel Capsules Sales Market Share by Company (2020-2022)
3.2 Global Non-Animal Softgel Capsules Annual Revenue by Company (2020-2022)
3.2.1 Global Non-Animal Softgel Capsules Revenue by Company (2020-2022)
3.2.2 Global Non-Animal Softgel Capsules Revenue Market Share by Company (2020-2022)
3.3 Global Non-Animal Softgel Capsules Sale Price by Company
3.4 Key Manufacturers Non-Animal Softgel Capsules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-Animal Softgel Capsules Product Location Distribution
3.4.2 Players Non-Animal Softgel Capsules Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Non-Animal Softgel Capsules by Geographic Region
4.1 World Historic Non-Animal Softgel Capsules Market Size by Geographic Region (2017-2022)
4.1.1 Global Non-Animal Softgel Capsules Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Non-Animal Softgel Capsules Annual Revenue by Geographic Region
4.2 World Historic Non-Animal Softgel Capsules Market Size by Country/Region (2017-2022)
4.2.1 Global Non-Animal Softgel Capsules Annual Sales by Country/Region (2017-2022)
4.2.2 Global Non-Animal Softgel Capsules Annual Revenue by Country/Region
4.3 Americas Non-Animal Softgel Capsules Sales Growth
4.4 APAC Non-Animal Softgel Capsules Sales Growth
4.5 Europe Non-Animal Softgel Capsules Sales Growth
4.6 Middle East & Africa Non-Animal Softgel Capsules Sales Growth
5 Americas
5.1 Americas Non-Animal Softgel Capsules Sales by Country
5.1.1 Americas Non-Animal Softgel Capsules Sales by Country (2017-2022)
5.1.2 Americas Non-Animal Softgel Capsules Revenue by Country (2017-2022)
5.2 Americas Non-Animal Softgel Capsules Sales by Type
5.3 Americas Non-Animal Softgel Capsules Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Animal Softgel Capsules Sales by Region
6.1.1 APAC Non-Animal Softgel Capsules Sales by Region (2017-2022)
6.1.2 APAC Non-Animal Softgel Capsules Revenue by Region (2017-2022)
6.2 APAC Non-Animal Softgel Capsules Sales by Type
6.3 APAC Non-Animal Softgel Capsules Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non-Animal Softgel Capsules by Country
7.1.1 Europe Non-Animal Softgel Capsules Sales by Country (2017-2022)
7.1.2 Europe Non-Animal Softgel Capsules Revenue by Country (2017-2022)
7.2 Europe Non-Animal Softgel Capsules Sales by Type
7.3 Europe Non-Animal Softgel Capsules Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-Animal Softgel Capsules by Country
8.1.1 Middle East & Africa Non-Animal Softgel Capsules Sales by Country (2017-2022)
8.1.2 Middle East & Africa Non-Animal Softgel Capsules Revenue by Country (2017-2022)
8.2 Middle East & Africa Non-Animal Softgel Capsules Sales by Type
8.3 Middle East & Africa Non-Animal Softgel Capsules Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-Animal Softgel Capsules
10.3 Manufacturing Process Analysis of Non-Animal Softgel Capsules
10.4 Industry Chain Structure of Non-Animal Softgel Capsules
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-Animal Softgel Capsules Distributors
11.3 Non-Animal Softgel Capsules Customer
12 World Forecast Review for Non-Animal Softgel Capsules by Geographic Region
12.1 Global Non-Animal Softgel Capsules Market Size Forecast by Region
12.1.1 Global Non-Animal Softgel Capsules Forecast by Region (2023-2028)
12.1.2 Global Non-Animal Softgel Capsules Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-Animal Softgel Capsules Forecast by Type
12.7 Global Non-Animal Softgel Capsules Forecast by Application
13 Key Players Analysis
13.1 Catalent
13.1.1 Catalent Company Information
13.1.2 Catalent Non-Animal Softgel Capsules Product Offered
13.1.3 Catalent Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Catalent Main Business Overview
13.1.5 Catalent Latest Developments
13.2 Procaps Laboratorios
13.2.1 Procaps Laboratorios Company Information
13.2.2 Procaps Laboratorios Non-Animal Softgel Capsules Product Offered
13.2.3 Procaps Laboratorios Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Procaps Laboratorios Main Business Overview
13.2.5 Procaps Laboratorios Latest Developments
13.3 EuroCaps
13.3.1 EuroCaps Company Information
13.3.2 EuroCaps Non-Animal Softgel Capsules Product Offered
13.3.3 EuroCaps Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 EuroCaps Main Business Overview
13.3.5 EuroCaps Latest Developments
13.4 Best Formulations
13.4.1 Best Formulations Company Information
13.4.2 Best Formulations Non-Animal Softgel Capsules Product Offered
13.4.3 Best Formulations Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Best Formulations Main Business Overview
13.4.5 Best Formulations Latest Developments
13.5 Aenova
13.5.1 Aenova Company Information
13.5.2 Aenova Non-Animal Softgel Capsules Product Offered
13.5.3 Aenova Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Aenova Main Business Overview
13.5.5 Aenova Latest Developments
13.6 Captek
13.6.1 Captek Company Information
13.6.2 Captek Non-Animal Softgel Capsules Product Offered
13.6.3 Captek Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Captek Main Business Overview
13.6.5 Captek Latest Developments
13.7 Sirio
13.7.1 Sirio Company Information
13.7.2 Sirio Non-Animal Softgel Capsules Product Offered
13.7.3 Sirio Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sirio Main Business Overview
13.7.5 Sirio Latest Developments
13.8 Bahrain Pharma
13.8.1 Bahrain Pharma Company Information
13.8.2 Bahrain Pharma Non-Animal Softgel Capsules Product Offered
13.8.3 Bahrain Pharma Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bahrain Pharma Main Business Overview
13.8.5 Bahrain Pharma Latest Developments
13.9 Robinson Pharma
13.9.1 Robinson Pharma Company Information
13.9.2 Robinson Pharma Non-Animal Softgel Capsules Product Offered
13.9.3 Robinson Pharma Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Robinson Pharma Main Business Overview
13.9.5 Robinson Pharma Latest Developments
13.10 Aland
13.10.1 Aland Company Information
13.10.2 Aland Non-Animal Softgel Capsules Product Offered
13.10.3 Aland Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Aland Main Business Overview
13.10.5 Aland Latest Developments
13.11 Fuji Capsule
13.11.1 Fuji Capsule Company Information
13.11.2 Fuji Capsule Non-Animal Softgel Capsules Product Offered
13.11.3 Fuji Capsule Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Fuji Capsule Main Business Overview
13.11.5 Fuji Capsule Latest Developments
13.12 Sunsho Pharmaceutical
13.12.1 Sunsho Pharmaceutical Company Information
13.12.2 Sunsho Pharmaceutical Non-Animal Softgel Capsules Product Offered
13.12.3 Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Sunsho Pharmaceutical Main Business Overview
13.12.5 Sunsho Pharmaceutical Latest Developments
13.13 Erkang
13.13.1 Erkang Company Information
13.13.2 Erkang Non-Animal Softgel Capsules Product Offered
13.13.3 Erkang Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Erkang Main Business Overview
13.13.5 Erkang Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Non-Animal Softgel Capsules Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Non-Animal Softgel Capsules Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Plant Polysaccharides Softgel Capsules
Table 4. Major Players of Starch Softgel Capsules
Table 5. Global Non-Animal Softgel Capsules Sales by Type (2017-2022) & (M Capsules)
Table 6. Global Non-Animal Softgel Capsules Sales Market Share by Type (2017-2022)
Table 7. Global Non-Animal Softgel Capsules Revenue by Type (2017-2022) & ($ million)
Table 8. Global Non-Animal Softgel Capsules Revenue Market Share by Type (2017-2022)
Table 9. Global Non-Animal Softgel Capsules Sale Price by Type (2017-2022) & (US$/Capsule)
Table 10. Global Non-Animal Softgel Capsules Sales by Application (2017-2022) & (M Capsules)
Table 11. Global Non-Animal Softgel Capsules Sales Market Share by Application (2017-2022)
Table 12. Global Non-Animal Softgel Capsules Revenue by Application (2017-2022)
Table 13. Global Non-Animal Softgel Capsules Revenue Market Share by Application (2017-2022)
Table 14. Global Non-Animal Softgel Capsules Sale Price by Application (2017-2022) & (US$/Capsule)
Table 15. Global Non-Animal Softgel Capsules Sales by Company (2020-2022) & (M Capsules)
Table 16. Global Non-Animal Softgel Capsules Sales Market Share by Company (2020-2022)
Table 17. Global Non-Animal Softgel Capsules Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Non-Animal Softgel Capsules Revenue Market Share by Company (2020-2022)
Table 19. Global Non-Animal Softgel Capsules Sale Price by Company (2020-2022) & (US$/Capsule)
Table 20. Key Manufacturers Non-Animal Softgel Capsules Producing Area Distribution and Sales Area
Table 21. Players Non-Animal Softgel Capsules Products Offered
Table 22. Non-Animal Softgel Capsules Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Non-Animal Softgel Capsules Sales by Geographic Region (2017-2022) & (M Capsules)
Table 26. Global Non-Animal Softgel Capsules Sales Market Share Geographic Region (2017-2022)
Table 27. Global Non-Animal Softgel Capsules Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Non-Animal Softgel Capsules Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Non-Animal Softgel Capsules Sales by Country/Region (2017-2022) & (M Capsules)
Table 30. Global Non-Animal Softgel Capsules Sales Market Share by Country/Region (2017-2022)
Table 31. Global Non-Animal Softgel Capsules Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Non-Animal Softgel Capsules Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Non-Animal Softgel Capsules Sales by Country (2017-2022) & (M Capsules)
Table 34. Americas Non-Animal Softgel Capsules Sales Market Share by Country (2017-2022)
Table 35. Americas Non-Animal Softgel Capsules Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Non-Animal Softgel Capsules Revenue Market Share by Country (2017-2022)
Table 37. Americas Non-Animal Softgel Capsules Sales by Type (2017-2022) & (M Capsules)
Table 38. Americas Non-Animal Softgel Capsules Sales Market Share by Type (2017-2022)
Table 39. Americas Non-Animal Softgel Capsules Sales by Application (2017-2022) & (M Capsules)
Table 40. Americas Non-Animal Softgel Capsules Sales Market Share by Application (2017-2022)
Table 41. APAC Non-Animal Softgel Capsules Sales by Region (2017-2022) & (M Capsules)
Table 42. APAC Non-Animal Softgel Capsules Sales Market Share by Region (2017-2022)
Table 43. APAC Non-Animal Softgel Capsules Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Non-Animal Softgel Capsules Revenue Market Share by Region (2017-2022)
Table 45. APAC Non-Animal Softgel Capsules Sales by Type (2017-2022) & (M Capsules)
Table 46. APAC Non-Animal Softgel Capsules Sales Market Share by Type (2017-2022)
Table 47. APAC Non-Animal Softgel Capsules Sales by Application (2017-2022) & (M Capsules)
Table 48. APAC Non-Animal Softgel Capsules Sales Market Share by Application (2017-2022)
Table 49. Europe Non-Animal Softgel Capsules Sales by Country (2017-2022) & (M Capsules)
Table 50. Europe Non-Animal Softgel Capsules Sales Market Share by Country (2017-2022)
Table 51. Europe Non-Animal Softgel Capsules Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Non-Animal Softgel Capsules Revenue Market Share by Country (2017-2022)
Table 53. Europe Non-Animal Softgel Capsules Sales by Type (2017-2022) & (M Capsules)
Table 54. Europe Non-Animal Softgel Capsules Sales Market Share by Type (2017-2022)
Table 55. Europe Non-Animal Softgel Capsules Sales by Application (2017-2022) & (M Capsules)
Table 56. Europe Non-Animal Softgel Capsules Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Non-Animal Softgel Capsules Sales by Country (2017-2022) & (M Capsules)
Table 58. Middle East & Africa Non-Animal Softgel Capsules Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Non-Animal Softgel Capsules Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Non-Animal Softgel Capsules Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Non-Animal Softgel Capsules Sales by Type (2017-2022) & (M Capsules)
Table 62. Middle East & Africa Non-Animal Softgel Capsules Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Non-Animal Softgel Capsules Sales by Application (2017-2022) & (M Capsules)
Table 64. Middle East & Africa Non-Animal Softgel Capsules Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Non-Animal Softgel Capsules
Table 66. Key Market Challenges & Risks of Non-Animal Softgel Capsules
Table 67. Key Industry Trends of Non-Animal Softgel Capsules
Table 68. Non-Animal Softgel Capsules Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Non-Animal Softgel Capsules Distributors List
Table 71. Non-Animal Softgel Capsules Customer List
Table 72. Global Non-Animal Softgel Capsules Sales Forecast by Region (2023-2028) & (M Capsules)
Table 73. Global Non-Animal Softgel Capsules Sales Market Forecast by Region
Table 74. Global Non-Animal Softgel Capsules Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Non-Animal Softgel Capsules Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Non-Animal Softgel Capsules Sales Forecast by Country (2023-2028) & (M Capsules)
Table 77. Americas Non-Animal Softgel Capsules Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Non-Animal Softgel Capsules Sales Forecast by Region (2023-2028) & (M Capsules)
Table 79. APAC Non-Animal Softgel Capsules Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Non-Animal Softgel Capsules Sales Forecast by Country (2023-2028) & (M Capsules)
Table 81. Europe Non-Animal Softgel Capsules Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Non-Animal Softgel Capsules Sales Forecast by Country (2023-2028) & (M Capsules)
Table 83. Middle East & Africa Non-Animal Softgel Capsules Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Non-Animal Softgel Capsules Sales Forecast by Type (2023-2028) & (M Capsules)
Table 85. Global Non-Animal Softgel Capsules Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Non-Animal Softgel Capsules Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Non-Animal Softgel Capsules Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Non-Animal Softgel Capsules Sales Forecast by Application (2023-2028) & (M Capsules)
Table 89. Global Non-Animal Softgel Capsules Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Non-Animal Softgel Capsules Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Non-Animal Softgel Capsules Revenue Market Share Forecast by Application (2023-2028)
Table 92. Catalent Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors
Table 93. Catalent Non-Animal Softgel Capsules Product Offered
Table 94. Catalent Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2020-2022)
Table 95. Catalent Main Business
Table 96. Catalent Latest Developments
Table 97. Procaps Laboratorios Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors
Table 98. Procaps Laboratorios Non-Animal Softgel Capsules Product Offered
Table 99. Procaps Laboratorios Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2020-2022)
Table 100. Procaps Laboratorios Main Business
Table 101. Procaps Laboratorios Latest Developments
Table 102. EuroCaps Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors
Table 103. EuroCaps Non-Animal Softgel Capsules Product Offered
Table 104. EuroCaps Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2020-2022)
Table 105. EuroCaps Main Business
Table 106. EuroCaps Latest Developments
Table 107. Best Formulations Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors
Table 108. Best Formulations Non-Animal Softgel Capsules Product Offered
Table 109. Best Formulations Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2020-2022)
Table 110. Best Formulations Main Business
Table 111. Best Formulations Latest Developments
Table 112. Aenova Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors
Table 113. Aenova Non-Animal Softgel Capsules Product Offered
Table 114. Aenova Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2020-2022)
Table 115. Aenova Main Business
Table 116. Aenova Latest Developments
Table 117. Captek Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors
Table 118. Captek Non-Animal Softgel Capsules Product Offered
Table 119. Captek Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2020-2022)
Table 120. Captek Main Business
Table 121. Captek Latest Developments
Table 122. Sirio Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors
Table 123. Sirio Non-Animal Softgel Capsules Product Offered
Table 124. Sirio Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2020-2022)
Table 125. Sirio Main Business
Table 126. Sirio Latest Developments
Table 127. Bahrain Pharma Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors
Table 128. Bahrain Pharma Non-Animal Softgel Capsules Product Offered
Table 129. Bahrain Pharma Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2020-2022)
Table 130. Bahrain Pharma Main Business
Table 131. Bahrain Pharma Latest Developments
Table 132. Robinson Pharma Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors
Table 133. Robinson Pharma Non-Animal Softgel Capsules Product Offered
Table 134. Robinson Pharma Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2020-2022)
Table 135. Robinson Pharma Main Business
Table 136. Robinson Pharma Latest Developments
Table 137. Aland Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors
Table 138. Aland Non-Animal Softgel Capsules Product Offered
Table 139. Aland Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2020-2022)
Table 140. Aland Main Business
Table 141. Aland Latest Developments
Table 142. Fuji Capsule Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors
Table 143. Fuji Capsule Non-Animal Softgel Capsules Product Offered
Table 144. Fuji Capsule Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2020-2022)
Table 145. Fuji Capsule Main Business
Table 146. Fuji Capsule Latest Developments
Table 147. Sunsho Pharmaceutical Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors
Table 148. Sunsho Pharmaceutical Non-Animal Softgel Capsules Product Offered
Table 149. Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2020-2022)
Table 150. Sunsho Pharmaceutical Main Business
Table 151. Sunsho Pharmaceutical Latest Developments
Table 152. Erkang Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors
Table 153. Erkang Non-Animal Softgel Capsules Product Offered
Table 154. Erkang Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2020-2022)
Table 155. Erkang Main Business
Table 156. Erkang Latest Developments
List of Figures
Figure 1. Picture of Non-Animal Softgel Capsules
Figure 2. Non-Animal Softgel Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-Animal Softgel Capsules Sales Growth Rate 2017-2028 (M Capsules)
Figure 7. Global Non-Animal Softgel Capsules Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Non-Animal Softgel Capsules Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Plant Polysaccharides Softgel Capsules
Figure 10. Product Picture of Starch Softgel Capsules
Figure 11. Global Non-Animal Softgel Capsules Sales Market Share by Type in 2021
Figure 12. Global Non-Animal Softgel Capsules Revenue Market Share by Type (2017-2022)
Figure 13. Non-Animal Softgel Capsules Consumed in Health Supplements
Figure 14. Global Non-Animal Softgel Capsules Market: Health Supplements (2017-2022) & (M Capsules)
Figure 15. Non-Animal Softgel Capsules Consumed in Pharmaceutical
Figure 16. Global Non-Animal Softgel Capsules Market: Pharmaceutical (2017-2022) & (M Capsules)
Figure 17. Non-Animal Softgel Capsules Consumed in Others
Figure 18. Global Non-Animal Softgel Capsules Market: Others (2017-2022) & (M Capsules)
Figure 19. Global Non-Animal Softgel Capsules Sales Market Share by Application (2017-2022)
Figure 20. Global Non-Animal Softgel Capsules Revenue Market Share by Application in 2021
Figure 21. Non-Animal Softgel Capsules Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Non-Animal Softgel Capsules Revenue Market Share by Company in 2021
Figure 23. Global Non-Animal Softgel Capsules Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Non-Animal Softgel Capsules Revenue Market Share by Geographic Region in 2021
Figure 25. Global Non-Animal Softgel Capsules Sales Market Share by Region (2017-2022)
Figure 26. Global Non-Animal Softgel Capsules Revenue Market Share by Country/Region in 2021
Figure 27. Americas Non-Animal Softgel Capsules Sales 2017-2022 (M Capsules)
Figure 28. Americas Non-Animal Softgel Capsules Revenue 2017-2022 ($ Millions)
Figure 29. APAC Non-Animal Softgel Capsules Sales 2017-2022 (M Capsules)
Figure 30. APAC Non-Animal Softgel Capsules Revenue 2017-2022 ($ Millions)
Figure 31. Europe Non-Animal Softgel Capsules Sales 2017-2022 (M Capsules)
Figure 32. Europe Non-Animal Softgel Capsules Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Non-Animal Softgel Capsules Sales 2017-2022 (M Capsules)
Figure 34. Middle East & Africa Non-Animal Softgel Capsules Revenue 2017-2022 ($ Millions)
Figure 35. Americas Non-Animal Softgel Capsules Sales Market Share by Country in 2021
Figure 36. Americas Non-Animal Softgel Capsules Revenue Market Share by Country in 2021
Figure 37. United States Non-Animal Softgel Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Non-Animal Softgel Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Non-Animal Softgel Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Non-Animal Softgel Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Non-Animal Softgel Capsules Sales Market Share by Region in 2021
Figure 42. APAC Non-Animal Softgel Capsules Revenue Market Share by Regions in 2021
Figure 43. China Non-Animal Softgel Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Non-Animal Softgel Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Non-Animal Softgel Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Non-Animal Softgel Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Non-Animal Softgel Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Non-Animal Softgel Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Non-Animal Softgel Capsules Sales Market Share by Country in 2021
Figure 50. Europe Non-Animal Softgel Capsules Revenue Market Share by Country in 2021
Figure 51. Germany Non-Animal Softgel Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Non-Animal Softgel Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Non-Animal Softgel Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Non-Animal Softgel Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Non-Animal Softgel Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Non-Animal Softgel Capsules Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Non-Animal Softgel Capsules Revenue Market Share by Country in 2021
Figure 58. Egypt Non-Animal Softgel Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Non-Animal Softgel Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Non-Animal Softgel Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Non-Animal Softgel Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Non-Animal Softgel Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Non-Animal Softgel Capsules in 2021
Figure 64. Manufacturing Process Analysis of Non-Animal Softgel Capsules
Figure 65. Industry Chain Structure of Non-Animal Softgel Capsules
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
